Rishi Laser provides precision sheet metal fabrication and assembly services, specializing in heavy engineering components for global manufacturers of construction equipment, power distribution systems, and rail transport.
The company lacks a durable moat as evidenced by an average ROCE of 5.9%, which is below the cost of capital. While they have long-standing relationships with major OEMs like Caterpillar, the business is highly capital-intensive with limited pricing power and high customer concentration.
Management has focused on aggressive capacity expansion, specifically the Malur facility, which led to significant execution delays and human capital friction. While debt levels are disciplined, the historical return on reinvested capital has been poor, resulting in negative average ROE.
The Malur facility expansion, which already suffered from execution delays and human capital friction, becomes a permanent drag on the balance sheet rather than a growth engine. The company's inability to earn its cost of capital persists as high customer concentration with Caterpillar leaves them as a price-taker in a capital-intensive industry. Over five years, the combination of negative average net margins and poor capital allocation erodes the equity base, while the low promoter skin-in-the-game results in a lack of urgency to protect minority shareholders during the downturn.
RichFakir rates Rishi Laser Ltd's business quality as poor — 35/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Rishi Laser Ltd is trading about 64% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Rishi Laser Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Rishi Laser Ltd's fair value is about ₹87 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →